Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified, providing hope for a cancer that is highly lethal. This new finding provides early evidence that there may be a benefit in targeting specific alterations in cancer cells with newer agents once a patient's tumor becomes resistant to temozolomide.
Biomarkers found that could be drug targets against a deadly form of brain cancer
- 22. 6 2022 (20:19)